Back

Adipose tissue/ heart lipid transport determines cardiac diastolic function

31 August 2024 (15:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Miscellaneous clinical studies in heart failure (3) Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Giuseppe Trimarchi

Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
Is there an association of anthracyclines with HFrEF and/or HFpEF in patients treated for breast cancer or lymphoma after 30 years of follow-up? Insights from the Rochester epidemiology project
Doctor E. Tellez Garcia (Rochester, US)
Abstract Slides Video
Presentation thumbnail
A new heart transplant resource: DBD donor with out-of-hospital cardiac arrest
Doctor G. Fischetti (Bari, IT)
Abstract Slides Video
Presentation thumbnail
Circulating metabolites in patients with chronic heart failure are related to increased lipid utilisation but not to gut microbiota alterations
Doctor A. Nendl (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Ivabradine prevents doxorubicin-induced cardiotoxicity via attenuating mitochondrial dysfunction and mitochondrial dynamic imbalance in H9C2 cells and rats
Doctor A. Sripusanapan (Chiang Mai, TH)
Abstract Slides Video

Access the full session

Session thumbnail
Miscellaneous clinical studies in heart failure (3)

The Event

Event poster

ESC Congress 2024

31 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
Targeting adipose tissue metabolism to treat heart failure
thumbnail
Congress Presentation
Multicellular trajectories leading to subclinical diastolic dysfunction and HFpEF progression in cardiometabolic comorbidities.
thumbnail
Congress Session
Tackling adipose tissue to prevent heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources